INS and diabetes mellitus: Indeed, the vasodilator prostaglandin E1 has been shown to increase early absorption of human insulin in patients with diabetes (22), and infusion-site warming to increase local blood flow improves the pharmacokinetic (PK) profile of insulin analogues and lowers PPG excursions in patients with T1D using insulin pump therapy (23).